Home Cart 0 Sign in  
X

[ CAS No. 4294-95-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4294-95-5
Chemical Structure| 4294-95-5
Chemical Structure| 4294-95-5
Structure of 4294-95-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4294-95-5 ]

Related Doc. of [ 4294-95-5 ]

Alternatived Products of [ 4294-95-5 ]

Product Details of [ 4294-95-5 ]

CAS No. :4294-95-5 MDL No. :MFCD00667729
Formula : C8H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :HHNWXQCVWVVVQZ-UHFFFAOYSA-N
M.W : 167.16 Pubchem ID :351010
Synonyms :

Calculated chemistry of [ 4294-95-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 44.3
TPSA : 72.55 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.98
Log Po/w (XLOGP3) : 0.34
Log Po/w (WLOGP) : 0.98
Log Po/w (MLOGP) : -0.37
Log Po/w (SILICOS-IT) : 0.5
Consensus Log Po/w : 0.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.33
Solubility : 7.84 mg/ml ; 0.0469 mol/l
Class : Very soluble
Log S (Ali) : -1.43
Solubility : 6.25 mg/ml ; 0.0374 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.53
Solubility : 4.91 mg/ml ; 0.0294 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.17

Safety of [ 4294-95-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4294-95-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4294-95-5 ]
  • Downstream synthetic route of [ 4294-95-5 ]

[ 4294-95-5 ] Synthesis Path-Upstream   1~34

  • 1
  • [ 3473-63-0 ]
  • [ 4294-95-5 ]
  • [ 16064-24-7 ]
YieldReaction ConditionsOperation in experiment
73%
Stage #1: for 12 h; Heating / reflux
Stage #2: With ammonia In 2-methoxy-ethanol at 25℃; for 0.5 h;
Method 31; 7-Methoxy-3H-quinazolin-4-one; A mixture of 2-amino-4-methoxy benzoic acid (Method 30; 4.85 g, 88.9 mmol) and formamidine acetate (18.49 g, 177.8 mmol) in 2-methoxyethanol (100 ml) was stirred at reflux for 12 h. The reaction mixture was cooled to 25 °C and diluted with 0.01 M ammonia (100 ml). The mixture was then stirred at 25 0C for 30 min and the resulting solid was collected by filtration. The solid was washed with 0.01M ammonia and water. The product was dried by high vacuum to obtain a light brown solid 11.5 g (73percent). NMR: 12.10 (s, br, IH), 8.05 (m, 2H), 7.10 (m, 2H), 3.90 (s, 3H); m/z 167.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 4963 - 4966
[2] Patent: WO2007/71963, 2007, A2, . Location in patent: Page/Page column 52
[3] Patent: CN104447769, 2016, B, . Location in patent: Paragraph 0056-0057
  • 2
  • [ 77287-34-4 ]
  • [ 4294-95-5 ]
  • [ 16064-24-7 ]
Reference: [1] Yakugaku Zasshi, 1943, vol. 63, p. 445,447[2] Chem.Abstr., 1951, p. 5156
[3] Journal of the Chemical Society, 1947, p. 890,894
[4] Chemistry and Biodiversity, 2018, vol. 15, # 6,
  • 3
  • [ 4294-95-5 ]
  • [ 55496-52-1 ]
Reference: [1] Journal of the Chemical Society, 1947, p. 890,894
[2] Patent: US9527885, 2016, B2,
[3] Patent: CN104447769, 2016, B,
  • 4
  • [ 4294-95-5 ]
  • [ 62484-31-5 ]
Reference: [1] Journal of the Chemical Society, 1947, p. 890,894
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
[3] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1452 - 1465
[4] Patent: US2016/90374, 2016, A1,
[5] Patent: WO2016/151144, 2016, A1,
[6] Patent: WO2018/5799, 2018, A1,
  • 5
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, # 48, p. 17605 - 17614
[2] Journal of the Chemical Society, 1947, p. 890,894
[3] Patent: US5688803, 1997, A,
  • 6
  • [ 57-13-6 ]
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
YieldReaction ConditionsOperation in experiment
48% at 155℃; for 16 h; A mixture of 2-amino-4-methoxybenzoic acid (1 g; 5.98 mmol) and urea (7.18 g; 120 mmol) was stirred at 155°C for 16 h. The reaction mixture was cooled to 100°C and then 3 mL of water was added. The mixture was cooled to room temperature and was filtered. 30 mL of 1 mol/L NaOH aqueous solution was added to dissolve the precipitate. After one hour, 4.2 mL of acetic acid was added dropwise and the resulting light brown precipitate was filtered and dried. 8 was obtained as a light brown powder (0.55 g; 2.9 mmol; 48 percent). 1H NMR (500 MHz; DMSO) δ 11.10 (brs, 1H, HNH), 10.55 (brs, 1H, HNH), 7.8 (d, J=8.63 Hz, 1H, Ha4), 6.77 (dd, J=2.44, 8.84 Hz, 1H, Ha5), 6.64 (d, J=2.43 Hz, 1H, Ha7), 3.82 (s, 3H, Hbl). 13C NMR (125 MHz; DMSO) δ 164.8 (Ca6), 162.8 (Ca2), 151 (Cal), 143.3 (Ca8), 129.3 (Ca4), 111 (Ca5), 108.2 (Ca3), 98.8 (Ca7), 56.1 (Cbl). HRMS-ESI (m/z) calculated for C9H8N203: 193.0489 [M+H]+ ; found: 193.0511
Reference: [1] Patent: WO2016/151144, 2016, A1, . Location in patent: Page/Page column 55; 56
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
  • 7
  • [ 590-28-3 ]
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 42, p. 6081 - 6083
  • 8
  • [ 33844-21-2 ]
  • [ 4294-95-5 ]
YieldReaction ConditionsOperation in experiment
100% With hydrogen In methanol at 20℃; for 18 h; Intermediate 113: 2-Amino-4-methoxybenzoic acid4-Methoxy-2-nitrobenzoic acid (3 g, 16.4 mmol) was hydrogenated over palladium on carbon (10percent, 300 mg) in methanol (80 mL) at room temperature and normal pressure for 18 hours. The reaction mixture was filtered through celite and concentrated to dryness under reduce pressure to give 2.50 g (100percent) of the product as a colorless solid.1H NMR (DMSO-d^ δ 3.70 (s, 3H); 6.09 (dd, IH); 6.23 (d, IH); 7.59 (d, IH).
99% With hydrogen In methanol at 20℃; Inert atmosphere Example 33. Preparation of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-7-methoxyquinazolin-4(3H)-one
[0270] A mixture of 2-nitro-4-methoxybenzoic acid (1.00 g, 5.10 mmol) in methanol (10.0 mL) was stirred at room temperature under nitrogen. Palladium on carbon (10percent wt, 50percent wet, 0.559 g, 0.255 mmol) was added. The round- bottomed flask was capped with a new septa and degassed under vacuum. The flask was charged with hydrogen and degassed again. This was repeated twice and a hydrogen-filled balloon was attached to the flask. The mixture was stirred at room temperature for 4 hours. Nitrogen was then bubbled through the mixture to displace any excess hydrogen. The mixture was filtered through celite 521 and the filtrate was concentrated under reduced pressure to provide 2-amino-4- methoxybenzoic acid (0.890 g, >;99percent) as an off-white solid. The crude material was used directly in the next step without characterization.[0271] A mixture of 2-amino-4-methoxybenzoic acid (0.490 g, 3.00 mmol), EDCI (1.12 g, 5.83 mmol), HOBt (0.788 g, 5.83 mmol), Λ/-methylmorpholine (0.590 g, 5.83 mmol) and 14.8 N NH4OH (0.781 ml_, 10.6 mmol) in THF was stirred at room temperature for 16 hours. The solvent was removed under reduced pressure, then the residue was diluted with EtOAc (100 ml_), washed with water (2 x 100 mL), then brine (100 ml_), dried over anhydrous Na2SO4, filtered, and the solvent was removed under reduced pressure to provide 2-amino-4- methoxybenzamide as a tan solid.[0272] A mixture of 2-amino-4-methoxybenzamide (0.490 g, 3.00 mmol), 4-(2-(tert-butyldimethylsilyloxy)ethoxy)-3,5-dimethylbenzaldehyde (0.925 g, 3.00 mmol), NaHSO3 (94percent, 0.468 g, 4.50 mmol), and p-TsOHΗ2O (0.171 g, 0.900 mmol) in benzene (10.0 mL) was heated at 800C for 36 hours. The mixture was cooled to room temperature and the solvent was removed under reduced pressure. The residue was diluted with EtOAc (50 mL), washed with water (50 mL) then brine (50 mL), dried over anhydrous Na2SO4, filtered, and the solvent was removed under reduced pressure to provide 2-(4-(2-(tert-butyldimethylsilyloxy)ethoxy)-3,5-dimethylphenyl)-7-methoxyquinazolin-4(3H)-one as a pink solid. The crude material was used directly in the next step without characterization.[0273] A mixture of 2-(4-(2-(tert-butyldimethylsilyloxy)ethoxy)-3,5-dimethylphenyl)-7-methoxyquinazolin-4(3H)-one (1.09 g, 2.30 mmol) in 1 M TBAF (11.6 mL, 11.6 mmol) was stirred at room temperature for 3 hours. The mixture was diluted with water (100 mL) and extracted with EtOAc (2 x 100 mL). The organic layers were combined, washed with saturated aqueous NH4CI (2 x 75 mL), then brine (100 mL), dried over anhydrous Na2SO4, filtered, and the solvent was removed under reduced pressure. The residue was purified over silica gel (12 g, EtOAc/hexanes), triturated in ether, and the product was freeze- dried from MeCN/H2O to yield the title compound (0.0960 g, 12percent) as a white solid. 1H NMR (300 MHz, DMSO-d6): δ 12.18 (s, 1H), 8.02 (d, J = 8.79 Hz, 1H), 7.91 (s, 2H), 7.16 (d, J = 2.46 Hz, 1 H), 7.07 (dd, J = 8.79, 2.46 Hz, 1 H), 4.90 (t, J = 5.53 Hz, 1 H), 3.91 (s, 3H), 3.89-3.82 (m, 2H), 3.77-3.67 (m, 2H), 2.32 (s, 6H), 2.22 (d, J = 6.92 Hz, 1H). MS (APCI) m/z 341 [C19H2oN2O4+H]+.
99% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; for 4 h; Inert atmosphere Example 28
Preparation of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-7-methoxyquinazolin-4(3H)-one
A mixture of 2-nitro-4-methoxybenzoic acid (1.00 g, 5.10 mmol) in methanol (10.0 mL) was stirred at room temperature under nitrogen.
Palladium on carbon (10percent wt, 50percent wet, 0.559 g, 0.255 mmol) was added.
The round-bottomed flask was capped with a new septa and degassed under vacuum.
The flask was charged with hydrogen and degassed again.
This was repeated twice and a hydrogen-filled balloon was attached to the flask.
The mixture was stirred at room temperature for 4 hours.
Nitrogen was then bubbled through the mixture to displace any excess hydrogen.
The mixture was filtered through celite 521 and the filtrate was concentrated under reduced pressure to provide 2-amino-4-methoxybenzoic acid (0.890 g, >99percent) as an off-white solid.
87.6% With hydrogen In methanol at 25℃; for 168 h; Method 30; 2-Amino-4-methoxy benzoic acid; A mixture of 4-methoxy-2-nitrobenzoic acid (20 g, 101.5 mmol), 10percent Pd/C (1.5 g) in MeOH (200 ml) was stirred at 25 °C under a hydrogen atmosphere for 168 h. The mixture was diluted with MeOH and filtered through diatomaceous earth. The organics were removed under reduced pressure to yield a light brown solid (14.85 g, 87.6percent). NMR: 7.65 (d, IH), 6.30 (s, IH), 6.15 (d, IH), 3.80 (s, 3H); m/z 167.
50% With hydrogen In NH4OH at 50℃; for 48 h; Compounds 1-3 were made using similar procedures to those in U. S. Patent No. 4,287, 341 which is herein incorporated by reference in its entirety for all purposes as if fully set forth herein. Compound 3 was reduced using standard hydrogenation conditions of 10percent Pd/C in NH40H at 50 C over 48 hours. The product was precipitated by neutralizing with glacial acetic acid, filtering, and washing with water and ether. Yields were about 50percent. Compound 5 was prepared in a manner similar to that disclosed in U. S. Patent No. 5,716, 993 herein incorporated by reference in its entirety for all purposes as if fully set forth herein.

Reference: [1] Patent: WO2006/134378, 2006, A1, . Location in patent: Page/Page column 112
[2] Patent: WO2010/123975, 2010, A1, . Location in patent: Page/Page column 101-102
[3] Patent: US2013/281398, 2013, A1, . Location in patent: Paragraph 0493; 0494
[4] Patent: US5599814, 1997, A,
[5] Patent: WO2007/71963, 2007, A2, . Location in patent: Page/Page column 52
[6] Journal of Organic Chemistry, 1997, vol. 62, # 5, p. 1240 - 1256
[7] Collection of Czechoslovak Chemical Communications, 1985, vol. 50, # 2, p. 519 - 537
[8] Patent: WO2004/18419, 2004, A2, . Location in patent: Page 265
[9] Chemische Berichte, 1918, vol. 51, p. 14
[10] Chemische Berichte, 1956, vol. 89, p. 2174,2178
[11] Journal of the Chemical Society, 1947, p. 1034,1037
[12] Zhurnal Obshchei Khimii, 1938, vol. 8, p. 884,887[13] Chem. Zentralbl., 1939, vol. 110, # I, p. 4324
[14] Journal of Organic Chemistry, 1953, vol. 18, p. 1380,1400
[15] Chemical and pharmaceutical bulletin, 1964, vol. 12, p. 696 - 705
[16] Chemische Berichte, 1961, vol. 94, p. 2295 - 2305
[17] Patent: US5614530, 1997, A,
[18] Patent: US5852035, 1998, A,
[19] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 14, p. 7021 - 7032
  • 9
  • [ 38487-91-1 ]
  • [ 4294-95-5 ]
Reference: [1] Patent: US5948775, 1999, A,
  • 10
  • [ 52351-75-4 ]
  • [ 4294-95-5 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 21, p. 3261 - 3273
[2] Synthetic Communications, 1994, vol. 24, # 4, p. 533 - 548
[3] Australian Journal of Chemistry, 1958, vol. 11, p. 225,228
[4] Journal of Medicinal Chemistry, 2006, vol. 49, # 8, p. 2440 - 2455
  • 11
  • [ 33844-21-2 ]
  • [ 7440-05-3 ]
  • [ 4294-95-5 ]
Reference: [1] Patent: US5942520, 1999, A,
[2] Patent: US5488055, 1996, A,
  • 12
  • [ 33844-21-2 ]
  • [ 118-92-3 ]
  • [ 4294-95-5 ]
Reference: [1] Patent: US4287341, 1981, A,
  • 13
  • [ 27191-09-9 ]
  • [ 4294-95-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 8, p. 2440 - 2455
  • 14
  • [ 536-90-3 ]
  • [ 4294-95-5 ]
Reference: [1] Synthetic Communications, 1994, vol. 24, # 4, p. 533 - 548
  • 15
  • [ 6966-87-6 ]
  • [ 4294-95-5 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 21, p. 3261 - 3273
[2] Synthetic Communications, 1994, vol. 24, # 4, p. 533 - 548
[3] Australian Journal of Chemistry, 1958, vol. 11, p. 225,228
  • 16
  • [ 621-42-1 ]
  • [ 4294-95-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1967, vol. 40, p. 1480 - 1487
  • 17
  • [ 50868-78-5 ]
  • [ 4294-95-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1912, vol. 388, p. 34
  • 18
  • [ 38469-83-9 ]
  • [ 4294-95-5 ]
Reference: [1] Journal of the Chemical Society, 1947, p. 1034,1037
  • 19
  • [ 96-96-8 ]
  • [ 4294-95-5 ]
Reference: [1] Journal of the Chemical Society, 1947, p. 1034,1037
  • 20
  • [ 17484-36-5 ]
  • [ 4294-95-5 ]
Reference: [1] Chemische Berichte, 1918, vol. 51, p. 14
  • 21
  • [ 50868-75-2 ]
  • [ 4294-95-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1912, vol. 388, p. 34
  • 22
  • [ 2836-00-2 ]
  • [ 4294-95-5 ]
Reference: [1] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 10, p. 464
[2] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 10, p. 463
  • 23
  • [ 4294-95-5 ]
  • [ 74317-85-4 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 13, p. 4445 - 4452
  • 24
  • [ 4294-95-5 ]
  • [ 54435-09-5 ]
Reference: [1] Chemical and pharmaceutical bulletin, 1964, vol. 12, p. 696 - 705
[2] Collection of Czechoslovak Chemical Communications, 1974, vol. 39, # 12, p. 3548 - 3559
[3] Patent: US5942520, 1999, A,
[4] Patent: US5488055, 1996, A,
[5] Patent: US5852035, 1998, A,
[6] Patent: US3996229, 1976, A,
[7] Patent: US3996229, 1976, A,
[8] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 5031 - 5037
[9] Journal of Organic Chemistry, 2017, vol. 82, # 4, p. 2263 - 2268
[10] Organic Letters, 2017, vol. 19, # 7, p. 1578 - 1581
  • 25
  • [ 7664-93-9 ]
  • [ 4294-95-5 ]
  • [ 54435-09-5 ]
Reference: [1] Patent: US5614530, 1997, A,
  • 26
  • [ 4294-95-5 ]
  • [ 21971-21-1 ]
Reference: [1] Zhurnal Obshchei Khimii, 1938, vol. 8, p. 884,887[2] Chem. Zentralbl., 1939, vol. 110, # I, p. 4324
  • 27
  • [ 4294-95-5 ]
  • [ 169045-04-9 ]
YieldReaction ConditionsOperation in experiment
100% With N-Bromosuccinimide In N,N-dimethyl-formamide at 0 - 20℃; for 1 h; To a solution of 2-amino-4-methoxybenzoic acid (4.00 g, 23.93 mmol) in DMF (120 mL) at 0 °C was added NBS (4.68 g, 26.3 mmol). The cooling bath was removedand the reaction mixture was warmed up to room temperature and was stirred at room temperature for 1 h. The mixture was cooled to 0 °C and was treated with saturated sodium sulfite solution (25 mL) and was stirred for 5 mm. The pH of the mixture was adjusted to pH = 3 using conc. HC1 (ca. 10-15 mL was added). The reaction mixture was transferred to a separatory funnel containing water (100 mL). Theaqueous layer was extracted with ether (1 x 250 mL then 4 x 100 mL). The combined organic layers were washed with water (3 x 50 mL), brine (50 mL), dried over MgSO4, filtered, and concentrated to afford 2-amino-5-bromo-4- methoxybenzoic acid (5.90 g, 100percent yield) as a solid: ‘H NMR (400 MHz, DMSOd6) ö 7.78 (s, 1H), 6.43 (s, 1H), 3.81 (s, 3H), 2.90 (s, 1H), 2.74 (s, 1H); MS (ESI) m/e228.0 [(M+H-H2O), calcd for C8H7BrNO2 228.0].
77% at 20 - 40℃; for 18 h; 2-amino-5-bromo-4-methoxybenzoic acid
2-amino-4-methoxybenzoic acid (5 g, 30 mmol) was suspended in acetic acid (100 mL) and bromine (0.57 mL, 11.25 mmol) added at RT.
The mixture was stirred approx. 15 h at RT, then additional bromine (0.2 mL, 3.75 mmol) was added and the reaction mixture held at 40° C. for 3 hours.
The reaction course was tracked by thin-film chromatography, the product filtered out and washed with a little water. (Yield: 5.63 g, 77percent)
1.3 g With N-Bromosuccinimide In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 4 h; To a mixture of 4-methoxyanthranilic acid (0.67 g, 4.0 mmol) in DCM (10 mL) and DMF (3 mL) was added NBS (0.71 g, 4.0 mmol) at 0 °C. The mixture was stirred at room temperature for 4 h, then concentrated and subjected to silica gel chromatography (5-100percent EtOAc/Heptane) to provide 2-amino-5-bromo-4-methoxybenzoic acid as a beige solid (1 .30 g, containing 1 equivalent succinamide). MS (M-1 ) = 244.3/246.3. 1H NMR (DMSO-d6) δ 7.76 (s, 1 H), 6.42 (s, 1 H), 3.79 (s, 3H). This material was used without further purification.
Reference: [1] Patent: WO2016/53794, 2016, A1, . Location in patent: Page/Page column 111
[2] Patent: US2009/69320, 2009, A1, . Location in patent: Page/Page column 68
[3] Patent: WO2014/169167, 2014, A1, . Location in patent: Page/Page column 87
[4] Patent: WO2015/17589, 2015, A1, . Location in patent: Page/Page column 98
  • 28
  • [ 4294-95-5 ]
  • [ 18107-18-1 ]
  • [ 50413-30-4 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 20℃; for 16 h; To a solution of 4-methoxyanthranilic acid (5.0 g, 30.0 mmol) in a mixtue of 10percent methanol in tetrahydrofuran (100 mL) was added dropwise (trimethylsilyl)diazomethane (2.0 M solution in diethyl ether, 18.0 mL, 36.0 mmol) at 0 °C. The reaction mixture was stirred for 16 hours at room temperature then quenched by the addition of glacial acetic acid (0.1 mL). The reaction mixture was concentrated and the residue was partitioned between saturated sodium bicarbonate (50 mL) and ethyl acetate (250 mL). The organic layer was separated and washed with water (50 mL), saturated sodium bicarbonate (50 mL) and brine (50 mL), dried over sodium sulfate, filtered and concentrated to give methyl 2-amino-4-methoxybenzoate as an oil (5.4 g, quantitative). MS (EI) for C9HnNO3: 182 (MH+).
74% at 0 - 20℃; for 1 h; To a solution of 2-amino-4-(methyloxy) benzoic acid (5 g, 30 mmol) in MeOH (30 mL) and toluene (60 mL) wasadded trimethylsilyldiazomethane (30 mL, 60 mmol). The reaction mixture was stirred atooc for 1 h. The reaction mixture was allowed to warm to rt and solvent was removed in5 vacuo. The crude material was purified by column chromatography (0 to 15percentEtOAC/hexanes) to provide 4.2 g of the title compound (74percent). MS: m/z: 182 [M+H+]
74% at 0℃; for 1 h; Step 1. Methyl 2-amino-4-methoxybenzoate: To a solution of 2-amino-4- (methyloxy) benzoic acid (5 g, 30 mmol) in MeOH (30 mL) and toluene (60 mL) was added trimethylsilyldiazomethane (30 mL, 60 mmol). The reaction mixture was stirred at 0°C for 1 h. The reaction mixture was allowed to warm to rt and solvent was removed in vacuo. The crude material was purified by column chromatography (0 to 15percent EtOAc/hexanes) to provide 4.2 g of the title compound (74percent). MS: m/z: 182 [M+H]+.
74% at 0℃; for 1 h; To a solution of 2-amino-4-(methyloxy) benzoic acid (5 g, 30 mmol) in MeOH (30 mL) and toluene (60 mL) was added trimethylsilyldiazomethane (30 mL, 60 mmol).
The reaction mixture was stirred at 0°C for 1 h.
The reaction mixture was allowed to warm to rt and solvent was removed in vacuo.
The crude material was purified by column chromatography (0 to 15percent EtOAC/hexanes) to provide 4.2 g of the title compound (74percent). MS: m/z: 182 [M+H]+.

Reference: [1] Patent: WO2010/135524, 2010, A1, . Location in patent: Page/Page column 219
[2] Patent: WO2013/25958, 2013, A1, . Location in patent: Page/Page column 69; 70
[3] Patent: WO2014/43446, 2014, A1, . Location in patent: Page/Page column 31
[4] Patent: EP2744501, 2016, B1, . Location in patent: Paragraph 0204; 0205
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3170 - 3181
  • 29
  • [ 67-56-1 ]
  • [ 4294-95-5 ]
  • [ 50413-30-4 ]
YieldReaction ConditionsOperation in experiment
75.92% for 24 h; Reflux To a solution of 2-amino-4-methoxybenzoic acid 33 (5.0 g,0.03 mol) in methanol (50 mL) was added strong sulphuricacid (9 mL). The solution was stirred at reflux for 24 h. Itwas cooled to room temperature and the pH of the mixturewas adjusted to 5~6 with saturated sodium carbonatesolution. The solution was extracted with EA (100 mL*2).The combined organic layers were washed with brine(50 mL), dried over Na2SO4, filtered and concentrated,affording white powder 34 (4.11 g, 75.92percent). 34: 1H NMR (400 MHz, CDCl3) 7.81 (d, J = 8.9 Hz, 1 H), 6.25 (dd, J =9.0, 2.5 Hz, 1H), 6.13 (d, J = 2.4 Hz, 1H), 5.80 (s, 2H), 3.86(s, 3H), 3.81 (s, 3H).
37% Reflux Step a): Methyl 2-amino-4-methoxybenzoate
1000 mg (6.0 mmol) of 2-amino-4-methoxybenzoic acid are reacted according to General Method I.
Yield: 400 mg (37percent of theory)
LC-MS (Method 3): Rt=1.96 min;
MS (ESIpos): m/z=182 [M+H]+.
5 mmol of the carboxylic acid are dissolved in 50 ml of methanol, and 5 ml of concentrated sulfuric acid are added. The mixture is heated under reflux for 14-24 h. After cooling to room temperature, the solution is poured onto ice and adjusted to pH 6 using sodium bicarbonate. After addition of 100 ml of dichloromethane, the aqueous phase is separated off and reextracted twice with in each case 50 ml of dichloromethane. The combined organic extracts are dried over sodium sulfate, filtered and concentrated under reduced pressure.
Reference: [1] Medicinal Chemistry Research, 2018, vol. 27, # 7, p. 1851 - 1862
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8332 - 8338
[3] Patent: US2010/4292, 2010, A1, . Location in patent: Page/Page column 12; 15
[4] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 21, p. 3261 - 3273
  • 30
  • [ 4294-95-5 ]
  • [ 50413-30-4 ]
Reference: [1] Patent: US4287341, 1981, A,
[2] Patent: US5599814, 1997, A,
  • 31
  • [ 4294-95-5 ]
  • [ 79025-82-4 ]
Reference: [1] Patent: CN107814792, 2018, A, . Location in patent: Paragraph 0295; 0296
  • 32
  • [ 4294-95-5 ]
  • [ 79025-82-4 ]
  • [ 1180495-74-2 ]
Reference: [1] MedChemComm, 2014, vol. 5, # 12, p. 1892 - 1898
  • 33
  • [ 4294-95-5 ]
  • [ 187731-65-3 ]
YieldReaction ConditionsOperation in experiment
66% With borane-THF In tetrahydrofuran at 0 - 20℃; for 1.66667 h; Inert atmosphere General procedure: To a solution of 6-chloroanthranilic acid (1.5 g, 8.74 mmol) in THF (5 mL) was added dropwise 1.08 M borane–tetrahydrofuran complex in THF (24.3 mL, 26.2 mmol) at 0 °C under an Ar atmosphere for 10 min. After 1.5 h with stirring at 30 °C, the solution was cooled at 0 °C, added aqueous THF (THF/H2O = 1:1, 60 mL) and potassium carbonate, and extracted with diethyl ether three times. The combined organic extracts were washed with brine, dried over Na2SO4, and evaporated in vacuo. The residue was crystallized from AcOEt to give 1a (1.2 g, 88percent) as a white needle crystal.
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 19, p. 5810 - 5831
[2] Patent: WO2014/11900, 2014, A2, . Location in patent: Page/Page column 72
[3] Angewandte Chemie, International Edition, 2014, vol. 53, # 36, p. 9603 - 9607,5[4] Angewandte Chemie, 2014, vol. 126, # 36, p. 9757 - 9761,5
[5] Patent: US2015/119405, 2015, A1, . Location in patent: Paragraph 0476; 0477; 0478
[6] Angewandte Chemie - International Edition, 2016, vol. 55, # 49, p. 15272 - 15276[7] Angew. Chem., 2016, vol. 128, # 49, p. 15498 - 15502,5
[8] Canadian Journal of Chemistry, 2016, vol. 94, # 4, p. 305 - 311
[9] Organic and Biomolecular Chemistry, 2018, vol. 16, # 12, p. 2039 - 2042
  • 34
  • [ 4294-95-5 ]
  • [ 953040-63-6 ]
Reference: [1] Patent: WO2014/11900, 2014, A2,
[2] Patent: US2015/119405, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4294-95-5 ]

Aryls

Chemical Structure| 50413-30-4

[ 50413-30-4 ]

Methyl 2-amino-4-methoxylbenzoate

Similarity: 0.96

Chemical Structure| 5653-40-7

[ 5653-40-7 ]

2-Amino-4,5-dimethoxybenzoic acid

Similarity: 0.95

Chemical Structure| 74165-74-5

[ 74165-74-5 ]

3-Amino-5-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 2475-80-1

[ 2475-80-1 ]

Methyl 2-amino-5-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26759-46-6

[ 26759-46-6 ]

Methyl 2-amino-4,5-dimethoxybenzoate

Similarity: 0.92

Ethers

Chemical Structure| 50413-30-4

[ 50413-30-4 ]

Methyl 2-amino-4-methoxylbenzoate

Similarity: 0.96

Chemical Structure| 5653-40-7

[ 5653-40-7 ]

2-Amino-4,5-dimethoxybenzoic acid

Similarity: 0.95

Chemical Structure| 74165-74-5

[ 74165-74-5 ]

3-Amino-5-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 2475-80-1

[ 2475-80-1 ]

Methyl 2-amino-5-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26759-46-6

[ 26759-46-6 ]

Methyl 2-amino-4,5-dimethoxybenzoate

Similarity: 0.92

Amines

Chemical Structure| 50413-30-4

[ 50413-30-4 ]

Methyl 2-amino-4-methoxylbenzoate

Similarity: 0.96

Chemical Structure| 5653-40-7

[ 5653-40-7 ]

2-Amino-4,5-dimethoxybenzoic acid

Similarity: 0.95

Chemical Structure| 74165-74-5

[ 74165-74-5 ]

3-Amino-5-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 2475-80-1

[ 2475-80-1 ]

Methyl 2-amino-5-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26759-46-6

[ 26759-46-6 ]

Methyl 2-amino-4,5-dimethoxybenzoate

Similarity: 0.92

Carboxylic Acids

Chemical Structure| 5653-40-7

[ 5653-40-7 ]

2-Amino-4,5-dimethoxybenzoic acid

Similarity: 0.95

Chemical Structure| 74165-74-5

[ 74165-74-5 ]

3-Amino-5-methoxybenzoic acid

Similarity: 0.95

Chemical Structure| 53600-33-2

[ 53600-33-2 ]

2-Amino-6-methoxybenzoic acid

Similarity: 0.92

Chemical Structure| 6705-03-9

[ 6705-03-9 ]

2-Amino-5-methoxybenzoic acid

Similarity: 0.88

Chemical Structure| 76045-71-1

[ 76045-71-1 ]

3-Amino-5-hydroxybenzoic acid

Similarity: 0.88